Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Key findings: 12 mg dose: Average weight loss of 24.2% of body weight (approximately 58 lbs for a 240 lb individual) 8 mg dose: Average weight loss of 22.8% 4 mg dose: Average weight loss of 17.0% Placebo: Average weight loss of 2.1% Over 90% of participants receiving the 8 mg or 12 mg dose lost at least 10% of body weight Over 75% of participants at the highest dose lost at least 20% of body weight Significant improvements in waist circumference, blood pressure, and lipid profiles were observed across dose groups Phase 2 Trial in Type 2 Diabetes A separate phase 2 trial evaluated retatrutide in adults with type 2 diabetes and obesity (Rosenstock et al., Lancet , 2023)
Many patients report: However, for patients with unresolved gut inflammation or adrenal dysfunction, semaglutide can exacerbate side effects such as nausea, fatigue, or constipation
The reference currently listed for Chen et al
Your care team reviews your labs, symptoms, and treatment response, provides coaching to improve outcomes, and offers guidance you can share with your prescribing clinician regarding dosing, tolerance, and long-term strategy.
Het veiligheidsprofiel van Retatrutide is tot nu toe acceptabel, maar de lange termijn moet nog blijken
Yes, protein does help with weight loss , especially in combination with GLP-1 therapy
